I-Mab Biopharma
IMAB
#9315
Rank
A$0.10 B
Marketcap
$1.26
Share price
0.00%
Change (1 day)
-54.07%
Change (1 year)

Earnings for I-Mab Biopharma (IMAB)

Earnings in 2024 (TTM): -A$0.3 Billion

According to I-Mab Biopharma's latest financial reports the company's current earnings are A$3.27 Million. a decrease over its 2023 earnings that were of -A$10.54 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for I-Mab Biopharma from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -A$78.21 Million642.25%
2023 -A$10.54 Million-11.48%
2022-A$11.91 Million-86.72%
2021-A$89.63 Million-605.96%
2020 A$17.71 M-138.32%
2019 -A$46.23 Million260.14%
2018 -A$12.84 Million19.49%
2017-A$10.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$28.31 Million-90.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$16.16 Million-94.81%๐Ÿ‡บ๐Ÿ‡ธ USA